Kevin Ohashi
Direttore/Membro del Consiglio presso MicroVascular Tissues, Inc.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Glen G. Gong | M | - |
MicroVascular Tissues, Inc.
MicroVascular Tissues, Inc. BiotechnologyHealth Technology MicroVascular Tissues, Inc. develops biological vascular tissues for implantation. The company is headquartered in San Diego, CA. | - |
Greg Lee | M | 77 |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | - |
Simon Williams | M | - |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | - |
Scott Roth | M | - |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | - |
Anthony Sinskey | M | 83 |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | - |
Jerome Meier | M | - |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | - |
Robert Goforth | M | - |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | - |
Dale L. Peterson | M | - |
MicroVascular Tissues, Inc.
MicroVascular Tissues, Inc. BiotechnologyHealth Technology MicroVascular Tissues, Inc. develops biological vascular tissues for implantation. The company is headquartered in San Diego, CA. | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 8 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Kevin Ohashi
- Contatti personali